{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:06:06Z","timestamp":1768417566816,"version":"3.49.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.tips.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:41:33Z","timestamp":1565260893000},"page":"655-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Neuro-regeneration Therapeutic for Alzheimer\u2019s Dementia: Perspectives on Neurotrophic Activity"],"prefix":"10.1016","volume":"40","author":[{"given":"Miao-Kun","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Alkon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2019.07.008_bb0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neurobiolaging.2003.12.020","article-title":"Lessons from the AN 1792 Alzheimer vaccine: lest we forget","volume":"25","author":"Robinson","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2019.07.008_bb0010","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tips.2019.07.008_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WAD.0000000000000291","article-title":"Cholinesterase inhibitors may not benefit mild cognitive impairment and mild Alzheimer disease dementia","volume":"33","author":"Han","year":"2019","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.tips.2019.07.008_bb0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.008_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (NY)"},{"key":"10.1016\/j.tips.2019.07.008_bb0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2019.07.008_bb0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.008_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.devcel.2018.06.005","article-title":"3D culture method for Alzheimer\u2019s disease modeling reveals interleukin-4 rescues A\u03b242-induced loss of human neural stem cell plasticity","volume":"46","author":"Papadimitriou","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tips.2019.07.008_bb0045","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1073\/pnas.0709311104","article-title":"A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC","volume":"104","author":"Hongpaisan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.5209-10.2011","article-title":"PKC\u03b5 activation prevents synaptic loss, A\u03b2 elevation, and cognitive deficits in Alzheimer\u2019s disease transgenic mice","volume":"31","author":"Hongpaisan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0055","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.07.008_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer\u2019s disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2019.07.008_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","article-title":"A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer\u2019s disease","volume":"78","author":"Davies","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tips.2019.07.008_bb0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.09.001","article-title":"Synaptic slaughter in Alzheimer\u2019s disease","volume":"24","author":"Coleman","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2019.07.008_bb0075","article-title":"Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial","volume":"15","author":"Lawlor","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.tips.2019.07.008_bb0080","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2019.07.008_bb0085","first-page":"S1","article-title":"APECS trial of the BACE1 inhibitor verubecestat for prodromal Alzheimer\u2019s disease","volume":"5","author":"Cummings","year":"2018","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau- targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2019.07.008_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/1673-5374.228714","article-title":"Roles of neural regeneration in memory pharmacology","volume":"13","author":"Sun","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0100","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1002\/jcp.26328","article-title":"Effects of microRNA-10a on synapse remodeling in hippocampal neurons and neuronal cell proliferation and apoptosis through the BDNF-TrkB signaling pathway in a rat model of Alzheimer\u2019s disease","volume":"233","author":"Wu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tips.2019.07.008_bb0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fnins.2019.00403","article-title":"L-Lactate promotes adult hippocampal neurogenesis","volume":"13","author":"Lev-Vachnish","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/acs.molpharmaceut.8b00939","article-title":"3\u03b2,23,28-Trihydroxy-12-oleanene 3\u03b2-caffeate from desmodium sambuense-induced neurogenesis in PC12 cells mediated by ER stress and BDNF-TrkB signaling pathways","volume":"16","author":"Cheng","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2019.07.008_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnsyn.2014.00005","article-title":"The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity","volume":"6","author":"Kellner","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0120","doi-asserted-by":"crossref","first-page":"17269","DOI":"10.1074\/jbc.M909538199","article-title":"Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels","volume":"275","author":"Tabuchi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.07.008_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA methylation in the mammalian genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tips.2019.07.008_bb0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/embr.201337723","article-title":"Cell intrinsic control of axon regeneration","volume":"15","author":"Mar","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tips.2019.07.008_bb0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2019.07.008_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2017.08.019","article-title":"Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer\u2019s disease","volume":"108","author":"Iulita","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41598-017-00794-5","article-title":"Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer\u2019s disease","volume":"7","author":"Kaminari","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.07.008_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","article-title":"Synaptic degeneration in Alzheimer\u2019s disease","volume":"118","author":"Arendt","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2019.07.008_bb0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.07.008_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrn1326","article-title":"Regeneration beyond the glial scar","volume":"5","author":"Silver","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0165","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopsych.2010.05.030","article-title":"Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer\u2019s disease progression","volume":"68","author":"Ginsberg","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2019.07.008_bb0170","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-141221","article-title":"PKC\u03b5 deficits in Alzheimer\u2019s disease brains and skin fibroblasts","volume":"43","author":"Khan","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0175","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.07.008_bb0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","article-title":"Beyond the neuron-cellular interactions early in Alzheimer\u2019s disease pathogenesis","volume":"20","author":"Henstridge","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/glia.10146","article-title":"Neuroinflammation in Alzheimer\u2019s disease and prion disease","volume":"40","author":"Eikelenboom","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.tips.2019.07.008_bb0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41467-018-08279-3","article-title":"Neuropathological correlates and genetic architecture of microglial activation in elderly human brain","volume":"10","author":"Felsky","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2019.07.008_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41593-017-0033-9","article-title":"The diversity and disparity of the glial scar","volume":"21","author":"Adams","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0200","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2019.07.008_bb0205","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","article-title":"Microglia-mediated synapse loss in Alzheimer\u2019s disease","volume":"38","author":"Rajendran","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-017-0814-9","article-title":"Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain","volume":"14","author":"Fonseca","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2019.07.008_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.008_bb0220","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1523\/JNEUROSCI.0584-17.2017","article-title":"Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury","volume":"37","author":"Hilla","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-150172","article-title":"Decreased neurotrophic support is associated with cognitive decline in non-demented subjects","volume":"46","author":"Forlenza","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0230","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00441-017-2782-x","article-title":"BDNF effects on dendritic spine morphology and hippocampal function","volume":"373","author":"von Bohlen Und Halbach","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrn1956","article-title":"Glial inhibition of CNS axon regeneration","volume":"7","author":"Yiu","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-016-0082-7","article-title":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy","volume":"11","author":"Barini","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2019.07.008_bb0245","doi-asserted-by":"crossref","first-page":"15468","DOI":"10.1523\/JNEUROSCI.2442-11.2011","article-title":"The role of PSD-95 and cypin in morphological changes in dendrites following sublethal NMDA exposure","volume":"31","author":"Tseng","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0250","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3389\/fneur.2018.01058","article-title":"The multidisciplinary approach to Alzheimer\u2019s disease and dementia. A narrative review of non-pharmacological treatment","volume":"9","author":"Zucchella","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2019.07.008_bb0255","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2019.07.008_bb0260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-160017","article-title":"A phase II study of fornix deep brain stimulation in mild Alzheimer\u2019s disease","volume":"54","author":"Lozano","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0265","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jagp.2013.02.018","article-title":"The effect of exercise training on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials","volume":"21","author":"Gates","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.tips.2019.07.008_bb0270","doi-asserted-by":"crossref","first-page":"E2403","DOI":"10.1073\/pnas.1718435115","article-title":"Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity","volume":"115","author":"Prado Lima","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0275","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2018.11.012","article-title":"Transcranial direct current stimulation induces hippocampal metaplasticity mediated by brain-derived neurotrophic factor","volume":"144","author":"Yu","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2019.07.008_bb0280","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4103\/1673-5374.241468","article-title":"Partial improvement in performance of patients with severe Alzheimer\u2019s disease at an early stage of fornix deep brain stimulation","volume":"13","author":"Mao","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0285","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.neubiorev.2013.09.002","article-title":"Deep brain stimulation in dementia-related disorders","volume":"37","author":"Hescham","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2019.07.008_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.wneu.2018.07.197","article-title":"Acute dementia after deep brain stimulation in Parkinson disease","volume":"119","author":"Puy","year":"2018","journal-title":"World Neurosurg."},{"key":"10.1016\/j.tips.2019.07.008_bb0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","article-title":"Alzheimer\u2019s disease, dementia, and stem cell therapy","volume":"8","author":"Duncan","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tips.2019.07.008_bb0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2018.12.034","article-title":"Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer\u2019s disease rats","volume":"1710","author":"Hu","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-018-0087-1","article-title":"New approaches for brain repair \u2013 from rescue to reprogramming","volume":"557","author":"Barker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.07.008_bb0310","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hipo.22794","article-title":"NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP\/PS1 transgenic mice","volume":"27","author":"Zhang","year":"2017","journal-title":"Hippocampus"},{"key":"10.1016\/j.tips.2019.07.008_bb0315","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer\u2019s disease and neuronal loss","volume":"25","author":"Ager","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.tips.2019.07.008_bb0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2016.12.019","article-title":"HuCNS-SC human NSCs fail to differentiate, form ectopic clusters, and provide no cognitive benefits in a transgenic model of Alzheimer\u2019s disease","volume":"8","author":"Marsh","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tips.2019.07.008_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt227","article-title":"Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an A\u03b2PP\/PS1 transgenic mouse model","volume":"4","author":"Yang","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tips.2019.07.008_bb0330","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.neurobiolaging.2013.03.029","article-title":"Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer\u2019s disease model","volume":"34","author":"Kim","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2019.07.008_bb0335","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2019.07.008_bb0340","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s11064-018-2586-8","article-title":"Resveratrol boosts cognitive function by targeting SIRT1","volume":"43","author":"Cao","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0345","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12035-010-8111-y","article-title":"Resveratrol as a therapeutic agent for neurodegenerative diseases","volume":"41","author":"Sun","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2019.07.008_bb0350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fncel.2015.00064","article-title":"SIRT1 in the brain-connections with aging-associated disorders and lifespan","volume":"9","author":"Ng","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0355","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1515\/chempap-2015-0134","article-title":"Molecular dynamic studies of amyloid-beta interactions with curcumin and Cu2+ ions","volume":"69","author":"Kozmon","year":"2015","journal-title":"Chem. Papers"},{"key":"10.1016\/j.tips.2019.07.008_bb0360","first-page":"742","article-title":"Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease","volume":"13","author":"Chen","year":"2019","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0365","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14737175.2015.1044981","article-title":"Clinical development of curcumin in neurodegenerative disease","volume":"15","author":"Hu","year":"2015","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.tips.2019.07.008_bb0370","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2019.07.008_bb0375","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-170512","article-title":"Protective effects of Indian spice curcumin against amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"61","author":"Reddy","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","article-title":"Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR","volume":"79","author":"McGeer","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2019.07.008_bb0385","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(90)91101-F","article-title":"Anti-inflammatory drugs and Alzheimer disease","volume":"335","author":"McGeer","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2019.07.008_bb0390","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer\u2019s disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0395","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ibror.2018.01.003","article-title":"Preventing synaptic deficits in Alzheimer\u2019s disease by inhibiting tumor necrosis factor alpha signaling","volume":"4","author":"Cavanagh","year":"2018","journal-title":"IBRO Rep."},{"key":"10.1016\/j.tips.2019.07.008_bb0400","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroscience.2015.01.058","article-title":"Donepezil improves learning and memory deficits in APP\/PS1 mice by inhibition of microglial activation","volume":"290C","author":"Guo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2019.07.008_bb0405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2019.07.008_bb0410","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2019.07.008_bb0415","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1533317514542644","article-title":"Role of traditional nonsteroidal anti-inflammatory drugs in Alzheimer\u2019s disease: a meta-analysis of randomized clinical trials","volume":"30","author":"Gupta","year":"2015","journal-title":"Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.tips.2019.07.008_bb0420","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2019.07.008_bb0425","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.tips.2017.07.005","article-title":"Early and late CNS inflammation in Alzheimer\u2019s disease: two extremes of a continuum?","volume":"38","author":"Cuello","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2019.07.008_bb0430","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2019.07.008_bb0435","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1742-2094-8-171","article-title":"Neuroinflammation in Alzheimer\u2019s disease wanes with age","volume":"8","author":"Hoozemans","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2019.07.008_bb0440","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE4 and A\u03b2 oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-011112-140216","article-title":"The potential of HDAC inhibitors as cognitive enhancers","volume":"53","author":"Gr\u00e4ff","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2019.07.008_bb0450","doi-asserted-by":"crossref","first-page":"E11148","DOI":"10.1073\/pnas.1805436115","article-title":"Inhibition of HDAC3 reverses Alzheimer\u2019s disease-related pathologies in vitro and in the 3xTg-AD mouse model","volume":"115","author":"Janczura","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0455","doi-asserted-by":"crossref","first-page":"15596","DOI":"10.1523\/JNEUROSCI.5195-12.2013","article-title":"Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice","volume":"33","author":"Nagahara","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0460","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1038\/tp.2016.186","article-title":"Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer\u2019s disease","volume":"6","author":"Jiao","year":"2016","journal-title":"Tranl. Psychiatry"},{"key":"10.1016\/j.tips.2019.07.008_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8821","article-title":"Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer\u2019s mouse model","volume":"361","author":"Choi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.07.008_bb0470","first-page":"2441","article-title":"Conditional BDNF delivery from astrocytes rescues memory deficits, spine density and synaptic properties in the 5xFAD mouse model of Alzheimer disease","volume":"39","author":"de Pins","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0475","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2015.04.004","article-title":"Towards universal therapeutics for memory disorders","volume":"36","author":"Sun","year":"2015","journal-title":"Trends in Pharmacol. Sci."},{"key":"10.1016\/j.tips.2019.07.008_bb0480","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3233\/JAD-170839","article-title":"A novel therapeutic approach to treat Alzheimer\u2019s disease by neurotrophic support during the period of synaptic compensation","volume":"62","author":"Baazaoui","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0485","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1073\/pnas.0805952105","article-title":"Post-stroke neuronal rescue and synaptogenesis mediated in vivo by PKC in adult brains","volume":"105","author":"Sun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0490","doi-asserted-by":"crossref","first-page":"34514","DOI":"10.1074\/jbc.M109.016683","article-title":"Reduction of beta-amyloid levels by novel PKC (epsilon) activators","volume":"284","author":"Nelson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.07.008_bb0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tips.2006.12.002","article-title":"PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer\u2019s disease","volume":"28","author":"Alkon","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2019.07.008_bb0500","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4103\/1673-5374.241471","article-title":"Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer\u2019s disease","volume":"13","author":"Xu","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tips.2019.07.008_bb0505","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3233\/JAD-171008","article-title":"Loss in PKC epsilon causes downregulation of MnSOD and BDNF expression in neurons of Alzheimer\u2019s disease hippocampus","volume":"63","author":"Sen","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0510","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-170161","article-title":"Bryostatin effects on cognitive function and PKC\u03b5 in Alzheimer\u2019s phase IIa and expanded access trials","volume":"58","author":"Nelson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0515","doi-asserted-by":"crossref","first-page":"14676","DOI":"10.1073\/pnas.0907842106","article-title":"Post-ischemic PKC activation rescues retrograde and anterograde long-term memory","volume":"106","author":"Sun","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0520","doi-asserted-by":"crossref","first-page":"15947","DOI":"10.1074\/jbc.M111.312710","article-title":"Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C\u03b5","volume":"287","author":"Sen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2019.07.008_bb0525","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-180759","article-title":"A randomized, double-blind, placebo-controlled, phase II study assessing safety, tolerability, and efficacy of bryostatin in the treatment of moderately severe to severe Alzheimer\u2019s disease","volume":"67","author":"Farlow","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0530","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1073\/pnas.1718683115","article-title":"The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer\u2019s disease","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0535","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/imm.12303","article-title":"Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis","volume":"143","author":"Li","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.tips.2019.07.008_bb0540","first-page":"3929","article-title":"Therapeutic effect of Rho kinase inhibitor FSD-C10 in a mouse model of Alzheimer\u2019s disease","volume":"16","author":"Gu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.tips.2019.07.008_bb0545","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.celrep.2018.07.020","article-title":"Genetic dissection of presynaptic and postsynaptic BDNF-TrkB signaling in synaptic efficacy of CA3-CA1 synapses","volume":"24","author":"Lin","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2019.07.008_bb0550","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.tips.2019.07.008_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors","volume":"5","author":"Dominy","year":"2019","journal-title":"Sci Adv."},{"key":"10.1016\/j.tips.2019.07.008_bb0560","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.25410","article-title":"Amyloid-\u03b2 immunotherapy for Alzheimer disease: is it now a long shot?","volume":"85","author":"Panza","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2019.07.008_bb0565","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","article-title":"Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo","volume":"22","author":"Busche","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0570","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1073\/pnas.1721694115","article-title":"\u03b2-Amyloid accumulation in the human brain after one night of sleep deprivation","volume":"115","author":"Shokri-Kojori","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.07.008_bb0575","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jchemneu.2016.11.007","article-title":"Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons","volume":"80","author":"Atasoy","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.tips.2019.07.008_bb0580","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-181300","article-title":"Can we prevent dementia and not prevent neurons from dying?","volume":"68","author":"Becker","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2019.07.008_bb0585","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","article-title":"Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells","volume":"16","author":"Mart\u00ednez-Serrano","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2019.07.008_bb0590","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/gt.2008.23","article-title":"AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment","volume":"15","author":"Kells","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.tips.2019.07.008_bb0595","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.18632\/aging.101518","article-title":"A promising connection between BDNF and Alzheimer\u2019s disease","volume":"10","author":"Giuffrida","year":"2018","journal-title":"Aging (Albany NY)"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719301452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719301452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:07:38Z","timestamp":1759050458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614719301452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":119,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0165614719301452"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2019.07.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-regeneration Therapeutic for Alzheimer\u2019s Dementia: Perspectives on Neurotrophic Activity","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}